Table 1 Heritable hyperparathyroidism syndromes
Syndrome | Gene (locus) | Parathyroid pathology* | Other features |
---|---|---|---|
Multiple endocrine neoplasia 1 (MEN) 1 | MEN1 (11q13) | Hyperplasia (90%) | Pituitary adenomas, pancreatic endocrine tumors, carcinoid tumors, adrenocortical tumors, facial angiofibromas, collagenomas, lipomas |
Multiple endocrine neoplasia 2a (MEN 2a) | RET (10q11.2) | Hyperplasia (30%) | Medullary thyroid carcinoma, pheochromocytoma |
Familial hypocalciuric hypercalcemia (FHH) | CaSR/heterozygous (3q13.3q21) | Mild hyperplasia | |
Neonatal severe primary hyperparathyroidism | CaSR/homozygous (3q 13.3q21) | Hyperplasia | |
Hyperparathyroidism-jaw tumor (HPT-JT) syndrome | HRPT2 (1q25-q32) | Cystic adenomas, carcinoma (15%) | Ossifying jaw fibromas; renal cysts, carcinomas; Wilms’ tumor |
Familial isolated hyperparathyroidism | MEN1 (11q13); CaSR (3q13.3-q21); HRPT2 (1q25-q32) | Hyperplasia, carcinoma | |
Familial hypercalcemic hypercalcuria (autosomal dominant mild HPT) | CaSR | Hyperplasia, adenoma |